Clinical Highlights #EULAR2019: Emapalumab, an IFN- gamma blocking monoclonal antibody, is effective in macrophage activation syndrome in patients with childhood-onset #SLE #PReS2019 @carmona_loreto >LA

We unfortunately missed out on it at #EULAR2019 but nice work and important paper from @CCalabreseDO @cappelliMD @MarieKostine @BetsyKirch @LCalabreseDO on PMR-like irAEs. An area worth exploring! https://t.co/IrEI7QzCPZ @RheumNow

• https://rmdopen.bmj.com/content/5/1/e000906

You can stop MTX in RA pts in low disease state after adding tofa 11 mg daily long acting for 24 Wks if CDAI <11 (Oral Shift) No diff btw continue vs D/C MTX. Some pts will be happy to stop MTX without loss of effect LBOOO4 #EULAR2019 @RheumNow

Sjogrens EULAR guidelines leave me dry! Lots of collaboration and work on guidelines but not much content which begs for RCTs in Sjogrens to help our pts. SP0190. But some recent RCTs recently + such as Leflunomide+ Hydroxychloroquine #EULAR2019 @RheumNow https://t.co/JZDcBLHai8

For PsA poly arthritis what do you usually start

What happens when you use very low doses for rituximab retreatment for RA? More flares, but interesting mean disease activity/B cells comparison suggest most get by fine and fewer get infections #EULAR2019 LB0010 from Nijmegen @RheumNow https://t.co/opsUMPwOFd

RA confers a similar risk of inpatient admission for influenza as age >65yo in a large Australian general medical cohort. When will our RA patients get similar access to high dose influenza vaccine as patients >65yo do? #EULAR2019 FRI0058 @bonnialiu @earlyARA @RheumNow https://t.co/hR1fYHdZzQ

"My confidence & zest for life back again", "Being a good mum", "Not having to think about ways to conserve energy". The #patient view of #remission involves the symptoms of the disease, as well as its manifestations. Ruth Williams at #EULAR2019 https://t.co/uzaF7lXuEg

Some very good & practical suggestions for how to improve function and patient #remission suggested by Ruth Williams: good continuity of care & communication; holistic approach to physio, OT & podiatry; CBT; exercise classes & simple aids. #EULAR2019 https://t.co/OHxLjV7Syj

Great talk from @EATC4Children Prof Ramanan on uveitis and current therapeutic options #EULAR2019 https://t.co/44RuFyr1JM

RheumNow expanded twitter coverage of the #EULAR2019 annual meeting is sponsored by Horizon Pharma. All content chosen by RheumNow & its Faculty.

RA-ILD therapy: some very useful thoughts from @TobyMMaher, a respiratory expert from Royal Brompton #EULAR2019 SP0199 @RheumNow https://t.co/6Y7HziX4Kc

20% of patients post-total KNEE replacement have chronic pain vs 5% of patients post-total HIP replacement We don’t know why @larhumato #eular2019

Does Rheumatoid Arthritis Really Improve During Pregnancy? A Systematic Review and Metaanalysis 👉🏻Disease activity improved in 60% of patients with RA in pregnancy and flared in 46.7% postpartum. https://t.co/QKun6vOzDY #EULAR2019 Thanks @montesa_maria https://t.co/9QA84ITapO

• Does Rheumatoid Arthritis Really Improve During Pregnancy? A Systematic Review …

EULAR large vessel guidelines say if refractory GCA consider addition of Tocilizumab or MTX to steroids. Whereas in TAkayasu's you should start with immunosuppressive + steroids SP0192 #EULAR2019 @RheumNow https://t.co/Sn1j5Pqzgu